Eye Telescope Aproved

Image via Wikipedia

After five years, the Food and Drug Administration finally approved after a telescope eye degeneration makulêre treat the leading cause of blindness in the U. S. The Implantable Miniature Telescope (IMT) was developed by VisionCare Ophthalmic Technologies, Inc. Centrasight as part of a new system of care for patients dealing with end-stage age-related makulêre degeneration (AMD).

More than 10 million people in the U.S. alone suffer makulêre degeneration which is the biggest cause of blindness in people older than 55 years. Of those, 1.7 million suffer from advanced AMD, which had little or no clinical response to date. AMD is a disease of the central retina or macula, the part of the eye that can explain and more distinct, fundamental skills such as recognizing faces, too. For many, the central vision is blurred or completely dark, which prevented all the daily activities. Visual impairment suffered in the final stages of AMD, which both eyes are at an advanced stage of the disease often leads to loss of independence and isolation of patients.

The implant is adjustable to improve visual acuity by reducing the impact of the blind spot. The IMT, a device smaller than a pea, is surgically implanted in a cornea and acts an input image is too large for the peripheral parts of the retina that are damaged. Central vision is to be better in one eye while the other still more about the peripheral vision for mobility and orientation to receive.


CONTINUE READING 

Related articles by Zemanta

• FDA Approves First Implantable Miniature Telescope to Improve Sight of AMD Patients (prnewswire.com)
• Implantable Eye Telescope Finally FDA Approved (science.slashdot.org)
• FDA clears first implantable telescope for vision (sfgate.com)
• Eye telescope implant approved by U.S. FDA (ctv.ca)